European Industry Urges State Aid Changes To Allow COVID Recovery
Medicines For Europe Calls For Five-Year Temporary Relief To Permit Investment
A five-year period of temporary relief from EU state aid rules should be introduced for countries willing to invest in API and medicine production, Medicines for Europe has urged, insisting that current restrictions do not allow the investment necessary to bolster the supply chain in the wake of COVID-19.
